会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • SYSTEMS AND METHODS FOR MANAGING NOISE IN IMPLANTABLE MEDICAL DEVICES
    • 用于管理可植入医疗设备中的噪声的系统和方法
    • US20100318151A1
    • 2010-12-16
    • US12815871
    • 2010-06-15
    • Sunipa SahaEric K. EnroothScot C. Boon
    • Sunipa SahaEric K. EnroothScot C. Boon
    • A61N1/37G01R29/26G06F19/00
    • A61N1/371A61B5/0428A61B5/0432A61B5/7203A61B5/7217A61N1/3714A61N1/3718G06K9/0051
    • Embodiments of the invention are related to managing noise in sensed signals in implantable medical devices, amongst other things. In an embodiment the invention includes a method for processing electrical signals obtained from a patient including gathering a first set of electrical signals using an implantable medical device, filtering to provide a second set of electrical signals, the second set including frequencies above a threshold frequency, and estimating the amount of noise present in the first set of electrical signals based on the magnitude of the second set. In an embodiment, the invention includes a medical device configured to gather a first set of electrical signals, filter the first set to provide a second set of electrical signals including frequencies above a threshold frequency, and estimate the amount of noise present in the first set based on the magnitude of the second set. Other embodiments are also included herein.
    • 本发明的实施例涉及管理可植入医疗装置中的感测信号中的噪声等。 在一个实施例中,本发明包括一种用于处理从患者获得的电信号的方法,包括使用可植入医疗装置收集第一组电信号,滤波以提供第二组电信号,所述第二组包括高于阈值频率的频率, 以及基于第二组的大小来估计存在于第一组电信号中的噪声量。 在一个实施例中,本发明包括被配置为收集第一组电信号的医疗设备,对第一组进行滤波以提供包括高于阈值频率的频率的第二组电信号,以及估计第一组中存在的噪声量 基于第二组的大小。 本文还包括其它实施例。
    • 5. 发明授权
    • Systems and methods for managing noise in implantable medical devices
    • 用于管理可植入医疗设备中的噪声的系统和方法
    • US09345890B2
    • 2016-05-24
    • US12815871
    • 2010-06-15
    • Sunipa SahaEric K. EnroothScot C. Boon
    • Sunipa SahaEric K. EnroothScot C. Boon
    • A61N1/37A61B5/0428A61B5/0432A61B5/00G06K9/00
    • A61N1/371A61B5/0428A61B5/0432A61B5/7203A61B5/7217A61N1/3714A61N1/3718G06K9/0051
    • Embodiments of the invention are related to managing noise in sensed signals in implantable medical devices, amongst other things. In an embodiment the invention includes a method for processing electrical signals obtained from a patient including gathering a first set of electrical signals using an implantable medical device, filtering to provide a second set of electrical signals, the second set including frequencies above a threshold frequency, and estimating the amount of noise present in the first set of electrical signals based on the magnitude of the second set. In an embodiment, the invention includes a medical device configured to gather a first set of electrical signals, filter the first set to provide a second set of electrical signals including frequencies above a threshold frequency, and estimate the amount of noise present in the first set based on the magnitude of the second set. Other embodiments are also included herein.
    • 本发明的实施例涉及管理可植入医疗装置中的感测信号中的噪声等。 在一个实施例中,本发明包括一种用于处理从患者获得的电信号的方法,包括使用可植入医疗装置收集第一组电信号,滤波以提供第二组电信号,所述第二组包括高于阈值频率的频率, 以及基于第二组的大小来估计存在于第一组电信号中的噪声量。 在一个实施例中,本发明包括被配置为收集第一组电信号的医疗设备,对第一组进行滤波以提供包括高于阈值频率的频率的第二组电信号,以及估计第一组中存在的噪声量 基于第二组的大小。 本文还包括其它实施例。
    • 8. 发明申请
    • Dynamic Morphology Based Atrial Automatic Threshold
    • 基于动态形态的心房自动阈值
    • US20130013019A1
    • 2013-01-10
    • US13612077
    • 2012-09-12
    • Derek D. BohnAnkur GargEric K. Enrooth
    • Derek D. BohnAnkur GargEric K. Enrooth
    • A61N1/37
    • A61N1/371A61N1/3712
    • Methods and systems for performing capture threshold tests are described. During an initialization procedure a capture detection interval and capture detection threshold are determined based on peak values of cardiac signals sensed following the supracapture threshold initialization pulses. Following initialization, a plurality of pacing pulses to the atrium are delivered and the peak values of the cardiac signals sensed following each of the plurality of pacing pulses are determined. The peak values are compared to the pacing artifact threshold and the capture detection threshold. A timing of each of the peak values is compared to the capture detection interval. For each pacing pulse, discrimination between a captured response, a noncaptured response, and a fusion response is based on the peak value and timing comparisons.
    • 描述用于执行捕获阈值测试的方法和系统。 在初始化过程期间,捕获检测间隔和捕获检测阈值是基于超标准阈值初始化脉冲之后感测的心脏信号的峰值来确定的。 在初始化之后,传送到心房的多个起搏脉冲,并且确定在多个起搏脉冲之后检测到的心脏信号的峰值。 将峰值与起搏伪像阈值和捕获检测阈值进行比较。 将每个峰值的定时与捕获检测间隔进行比较。 对于每个起搏脉冲,捕获的响应,非捕获响应和融合响应之间的区别基于峰值和时序比较。
    • 9. 发明授权
    • Dynamic morphology based atrial automatic threshold
    • 动态形态基于心房自动阈值
    • US08290590B2
    • 2012-10-16
    • US11601217
    • 2006-11-17
    • Derek D. BohnAnkur GargEric K. Enrooth
    • Derek D. BohnAnkur GargEric K. Enrooth
    • A61N1/362
    • A61N1/371A61N1/3712
    • Methods and systems for performing capture threshold tests are described. During an initialization procedure a capture detection interval and capture detection threshold are determined based on peak values of cardiac signals sensed following the supracapture threshold initialization pulses. Following initialization, a plurality of pacing pulses to the atrium are delivered and the peak values of the cardiac signals sensed following each of the plurality of pacing pulses are determined. The peak values are compared to the pacing artifact threshold and the capture detection threshold. A timing of each of the peak values is compared to the capture detection interval. For each pacing pulse, discrimination between a captured response, a noncaptured response, and a fusion response is based on the peak value and timing comparisons.
    • 描述用于执行捕获阈值测试的方法和系统。 在初始化过程期间,捕获检测间隔和捕获检测阈值是基于超标准阈值初始化脉冲之后感测的心脏信号的峰值来确定的。 在初始化之后,传送到心房的多个起搏脉冲,并且确定在多个起搏脉冲之后检测到的心脏信号的峰值。 将峰值与起搏伪像阈值和捕获检测阈值进行比较。 将每个峰值的定时与捕获检测间隔进行比较。 对于每个起搏脉冲,捕获的响应,非捕获响应和融合响应之间的区别基于峰值和时序比较。
    • 10. 发明授权
    • Methods and systems for management of atrial retrograde conduction and pacemaker mediated tachyarrhythmia
    • 用于管理心房逆行传导和起搏器介导的快速性心律失常的方法和系统
    • US07801610B2
    • 2010-09-21
    • US11601092
    • 2006-11-17
    • Derek D. BohnAnkur GargEric K. Enrooth
    • Derek D. BohnAnkur GargEric K. Enrooth
    • A61N1/362
    • A61N1/371A61N1/3621A61N1/3712A61N1/3714
    • Methods and systems for classifying cardiac responses to pacing stimulation and managing retrograde conduction and pacemaker mediated tachyarrhythmia are described. An atrial pacing pulse and a ventricular pacing pulse are delivered during a paced cardiac cycle. A post ventricular atrial refractory period (PVARP) is timed following the ventricular pacing pulse. The system determines if the atrial pacing pulse captures the atrium. An atrial depolarization occurring after the paced cardiac cycle is sensed. Retrograde management is initiated if the atrial pacing pulse did not capture the atrium and the atrial depolarization occurred during the PVARP. Pacemaker mediated tachyarrhythmia (PMT) is initiated if the atrial pacing pulse did not capture the atrium and the atrial depolarization did not occur during the PVARP.
    • 描述了用于分类心脏起搏刺激响应和管理逆行传导和起搏器介导的快速性心律失常的方法和系统。 心律起搏脉搏和心室起搏脉搏在心跳期间进行。 心室起搏脉搏后定时心室心房不应期(PVARP)。 该系统确定心房起搏脉冲是否捕获心房。 感觉到起搏心动周期后出现心房去极化。 如果心房起搏脉搏没有捕获心房并且在PVARP期间发生心房去极化,则开始逆行管理。 如果心房起搏脉搏没有捕获心房并且在PVARP期间没有发生心房去极化,起搏器介导的快速性心律失常(PMT)开始。